Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H21ClN4 |
Molecular Weight | 304.818 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(CCN2CCN(CC2)C3=CC=CC(Cl)=C3)=NN1
InChI
InChIKey=DOTIMEKVTCOGED-UHFFFAOYSA-N
InChI=1S/C16H21ClN4/c1-13-11-15(19-18-13)5-6-20-7-9-21(10-8-20)16-4-2-3-14(17)12-16/h2-4,11-12H,5-10H2,1H3,(H,18,19)
CNS Activity
Originator
Sources: https://patents.google.com/patent/US3491097
Curator's Comment: reference retrieved from https://www.drugfuture.com/chemdata/mepiprazole.html
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Psychopharmological research with EMD 16-923 in patients with different degrees of anxiety]. | 1976 |
|
Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes. | 1976 Aug 17 |
|
1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole. | 1982 Oct |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
71897
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
5097
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
20326-12-9
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
DTXSID30174223
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
m306
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2106537
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
977BAL0NR7
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
SUB08751MIG
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
C66092
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
C008351
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
Mepiprazole
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
DB09197
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
2954
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY | |||
|
100000081497
Created by
admin on Sat Dec 16 16:52:14 GMT 2023 , Edited by admin on Sat Dec 16 16:52:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PARENT)
SALT/SOLVATE (PARENT)